Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F73MG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,093
Award facts
- Contract value 100% obligated
- $13,093.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,093.00 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors. This non-set-aside, competitively awarded contract was finalized on December 29, 2025, with an ultimate completion date of December 30, 2025. The award utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through the DLA Medical Supply Chain. The contractor's extensive federal contract portfolio demonstrates consistent capability in delivering specialty pharmaceuticals and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare programs. REPATHA (evolocumab) is a PCSK9 inhibitor used for cholesterol management in cardiovascular disease treatment, indicating this delivery order supports pharmaceutical needs within the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26F73MG?
SPE2DR26F73MG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F73MG worth?
The government has obligated $13,093 on SPE2DR26F73MG.
Is contract SPE2DR26F73MG an order under another contract?
Yes. SPE2DR26F73MG is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73MG competed?
The extent of competition for SPE2DR26F73MG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award